Myomo Inc MYO

Morningstar Rating
$1.61 −0.06 (3.59%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MYO is trading at a LOCK|bQ^PV premium.
Price
$1.61
Fair Value
LOCK|zVwr%k%
Uncertainty
LOCK|v! prRK
1-Star Price
LOCK|fN&!v!
5-Star Price
LOCK|pK!Q<@^
Economic Moat
LOCK|%tV
Capital Allocation
—

News

Trading Information

Previous Close Price
$1.67
Day Range
$1.59–1.78
52-Week Range
$0.61–1.89
Bid/Ask
$1.56 / $1.60
Shares Outstanding
39.61M
Market Cap
$63.77M
Volume/Avg
333,882 / 492,963

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.58
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
195

Valuation

Metric
MYO
Price/Earnings (Normalized)
—
Price/Book Value
10.92
Price/Sales
1.58
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
MYO
Quick Ratio
1.73
Current Ratio
2.31
Interest Coverage
−6.86
Quick Ratio
MYO

Profitability

Metric
MYO
Return on Assets (Normalized)
−33.53%
Return on Equity (Normalized)
−105.21%
Return on Invested Capital (Normalized)
−38.45%
Return on Assets
MYO

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|%Kx$wPLOCK|zQ%f$170B
Medtronic PLC
MDT
LOCK|#?>JNWLOCK|^yw%K$111B
Stryker Corp
SYK
LOCK|<gclNFDLOCK|Hb$107B
Boston Scientific Corp
BSX
LOCK|&<?k<&LOCK|%<xZ^$61B
Edwards Lifesciences Corp
EW
LOCK|t!mJH<mFLOCK|J!>b$50B
DexCom Inc
DXCM
LOCK|R<&CDW!fLOCK|$dJBF$31B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|ylWC$<ZLOCK|wD$29B
Koninklijke Philips NV ADR
PHG
LOCK|FQyLOCK|MMX$24B
Steris PLC
STE
LOCK|j@Vx#tCLOCK|#q&!m$20B
Zimmer Biomet Holdings Inc
ZBH
LOCK|k>!>h#jLOCK|zr$17B

Sponsor Center